Takura David Chonzi MBChB, MSc

David Chonzi is the Global Head of Patient Safety at Kite-a Gilead company. At Kite, he was responsible for building the PV system and leading the PV team which oversaw the approval of YESCARTA as one of the first CART therapies to be approved. He brings deep experience in Safety data analysis to support the approval of new therapies, forming highly functioning PV teams, and building safety systems. David also has experience with creating registries for post-approval studies as well as leading the integration of PV systems.`